ATOSSA THERAPEUTICS, INC. (ATOS) Net income 2016–2025
ATOSSA THERAPEUTICS, INC. (ATOS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$34.8MFY2025 · since FY2016: -$6.4M → -$34.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$34.8M | -36.3% |
| FY2024 | -$25.5M | +15.3% |
| FY2023 | -$30.1M | -11.6% |
| FY2022 | -$27.0M | -30.8% |
| FY2021 | -$20.6M | -15.6% |
| FY2020 | -$17.8M | -3.4% |
| FY2019 | -$17.2M | -51.2% |
| FY2018 | -$11.4M | -40.4% |
| FY2017 | -$8.1M | -27.5% |
| FY2016 | -$6.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ATOS financial trends
ATOS RevenueATOS Net marginATOS Gross profitATOS Gross marginATOS Operating incomeATOS Operating marginATOS Operating cash flowATOS Free cash flowATOS Capital expendituresATOS Return on equityATOS Stock buybacksATOS Dividends paidATOS Total assetsATOS Total liabilitiesATOS Shareholders’ equityATOS overview →